Document:

Exhibit 10.2

 

Execution Version

 

REGISTRATION RIGHTS AGREEMENT

 

This Registration Rights
Agreement (this “Agreement”) is made and entered into as of August  15 , 2016, between ARNO THERAPEUTICS,
INC., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such
purchaser, a “Purchaser” and, collectively, the “Purchasers”).

 

This Agreement is made
pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase
Agreement”).

 

The Company and each
Purchaser hereby agrees as follows:

 

1.             Definitions.

 

Capitalized terms
used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the
Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:

 

“Advice”
shall have the meaning set forth in Section 6(d).

 

“Agreement”
shall have the meaning set forth in the recital to this Agreement.

 

“Company”
shall have the meaning set forth in the recital to this Agreement.

 

“Effectiveness
Date” means, with respect to the Registration Statement required to be filed under Section 2(a), the 120th
calendar day following the date hereof; provided, however, that in the event the Company is notified by the Commission
that the Registration Statement will not be reviewed or is no longer subject to further review and comments, the Effectiveness
Date shall be the fifth Trading Day following the date on which the Company is so notified if such date precedes the dates required
above; provided further, however, that if the Effectiveness Date falls on a Saturday, Sunday or other day on which
the Commission is not open for business, then the Effectiveness Date shall be extended to the next day on which the Commission
is open for business.

 

“Effectiveness
Period” shall have the meaning set forth in Section 2(a).

 

“Event”
shall have the meaning set forth in Section 2(d).

 

“Event
Date” shall have the meaning set forth in Section 2(d).

 

“Filing
Date” means, with respect to the Initial Registration Statement required hereunder, the 60th calendar day
following the date hereof and, with respect to any additional Registration Statements which may be required pursuant to Section
2(c) or Section 3(c), the earliest practical date on which the Company is permitted by SEC Guidance to file such additional Registration
Statement related to the Registrable Securities; provided further, however, that if the Filing Date falls on a Saturday,
Sunday or other day on which the Commission is not open for business, then the Filing Date shall be extended to the next day on
which the Commission is open for business.

 

     

     

    

 

“Holder”
or “Holders” means the holder or holders, as the case may be, from time to time of Registrable Securities.

 

“Indemnified
Party” shall have the meaning set forth in Section 5(c).

 

“Indemnifying
Party” shall have the meaning set forth in Section 5(c).

 

“Initial
Registration Statement” means the initial Registration Statement filed pursuant to this Agreement.

 

“Liquidated
Damages Shares” shall have the meaning set forth in Section 2(g).

 

“Losses”
shall have the meaning set forth in Section 5(a).

 

“Plan
of Distribution” shall have the meaning set forth in Section 2(a).

 

“Prospectus”
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated
by the Commission pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the
terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments
and supplements to the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to
be incorporated by reference in such Prospectus.

 

“Purchase
Agreement” shall have the meaning set forth in the recital to this Agreement.

 

“Purchaser”
or “Purchasers” shall have the meaning set forth in the recital to this Agreement.

 

“Registrable
Securities” means, as of any date of determination, (a) all of the Shares issued by the Company on the date hereof pursuant
to the Purchase Agreement, and (b) the Warrant Shares then issued and issuable upon exercise of the Warrants (assuming on such
date the Warrants are exercised in full without regard to any exercise limitations therein), and (c) any securities issued or then
issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing;
provided, however, that any such Registrable Securities shall cease to be Registrable Securities (and the Company
shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect thereto)
for so long as (i) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by the
Commission under the Securities Act and such Registrable Securities have been disposed of by the Holder in accordance with such
effective Registration Statement, (ii) such Registrable Securities have been previously sold in accordance with Rule 144, or (iii)
such securities become eligible for resale without volume or manner-of-sale restrictions and without current public information
pursuant to Rule 144 as set forth in a written opinion letter to such effect, addressed, delivered and acceptable to the Transfer
Agent and the affected Holders (assuming that such securities and any securities issuable upon exercise, conversion or exchange
of which, or as a dividend upon which, such securities were issued or are issuable, were at no time held by any Affiliate of the
Company pursuant to the terms), as reasonably determined by the Company, upon the advice of counsel to the Company.

 

    	 	2	 

     

    

 

“Registration
Statement” means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional
registration statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements
to any such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material
incorporated by reference or deemed to be incorporated by reference in any such registration statement.

 

“Rule
415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.

 

“Rule
424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.

 

“Selling
Stockholder Questionnaire” shall have the meaning set forth in Section 3(a).

 

“SEC
Guidance” means (a) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements
or requests of the Commission staff and (b) the Securities Act.

 

“2012
Registration Rights Agreement” shall mean that certain Registration Rights Agreement by and among the Company and certain
investors dated November 26, 2012, as amended from time to time.

 

    	 	3	 

     

    

 

2.             Shelf
Registration.

 

(a)          On
or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale
of all of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be
made on a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-3 (except if the
Company is not then eligible to register for resale the Registrable Securities on Form S-3, in which case such registration shall
be on another appropriate form in accordance herewith, subject to the provisions of Section 2(d)) and shall contain (unless otherwise
directed by at least two-thirds in interest of the Holders) substantially the “Plan of Distribution” attached
hereto as Annex A. Subject to the terms of this Agreement, the Company shall use its best efforts to cause a Registration
Statement filed under this Agreement (including, without limitation, under Section 3(c)) to be declared effective under the Securities
Act as promptly as possible after the filing thereof, but in any event no later than the Effectiveness Date, and shall use its
best efforts to keep such Registration Statement continuously effective under the Securities Act until all Registrable Securities
covered by such Registration Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume
or manner-of-sale restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance with the current
public information requirement under Rule 144, as determined by the counsel to the Company pursuant to a written opinion letter
to such effect, addressed and acceptable to the Transfer Agent and the affected Holders (the “Effectiveness Period”).
The Company shall telephonically request effectiveness of a Registration Statement as of 5:00 p.m. Eastern Time on a Trading Day.
The Company shall immediately notify the Holders via facsimile or by e-mail of the effectiveness of a Registration Statement (notice
shall be provided simultaneously to all Holders first via e-mail) within one Trading Day that the Company telephonically confirms
effectiveness with the Commission, which shall be the date requested for effectiveness of such Registration Statement. The Company
shall, by 9:30 a.m. Eastern Time on the Trading Day after the effective date of such Registration Statement, file a final Prospectus
with the Commission as required by Rule 424. Failure to so notify the Holder within one (1) Trading Date of such notification of
effectiveness or failure to file a final prospectus as foresaid shall be deemed an Event under Section 2(d).

 

    	 	4	 

     

    

 

(b)          
Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable
Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration
statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file
amendments to the Initial Registration Statement as required by the Commission (or additional Registration Statements if required
by the Commission), covering the maximum number of Registrable Securities permitted to be registered by the Commission, on Form
S-3 or such other form available to register for resale the Registrable Securities as a secondary offering, subject to the provisions
of Section 2(d); provided, however, that prior to filing such amendment, the Company shall be obligated to use diligent
efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the SEC Guidance,
including without limitation, Compliance and Disclosure Interpretation 612.09.

 

(c)          Notwithstanding
any other provision of this Agreement, if the Commission or any SEC Guidance sets forth a limitation on the number of Registrable
Securities permitted to be registered on a particular Registration Statement as a secondary offering (and notwithstanding that
the Company used diligent efforts to advocate with the Commission for the registration of all or a greater portion of Registrable
Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities, the number of Registrable Securities
to be registered on such Registration Statement will be reduced as follows: 

 

(i)          First,
the Company shall reduce or eliminate any securities to be included by any Person other than a Holder;

 

(ii)         Second,
the Company shall reduce any Shares issued by the Company on the date
hereof pursuant to the Purchase Agreement;

 

(iii)        Third,
the Company shall reduce Registrable Securities represented by Warrant Shares issued pursuant to the Warrants (applied, in the
case that some Warrant Shares may be registered, to the Holders on a pro rata basis based on the total number of unregistered Warrant
Shares held by such Holders).

 

In
the event of a cutback hereunder, the Company shall give the Holder at least five (5) Trading Days prior written notice along with
the calculations as to such Holder’s allotment. In the event the Company amends the Initial Registration Statement in accordance
with the foregoing, the Company will use its best efforts to file with the Commission, as promptly as allowed by Commission or
SEC Guidance provided to the Company or to registrants of securities in general, one or more registration statements on Form S-3
or such other form available to register for resale those Registrable Securities that were not registered for resale on the Initial
Registration Statement, as amended.

 

    	 	5	 

     

    

 

(d)          If:
(i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration
Statement without affording the Holders the opportunity to review and comment on the same as required by Section 3(a) herein, the
Company shall be deemed to have not satisfied this clause (i)), or (ii) the Company fails to file with the Commission a request
for acceleration of a Registration Statement in accordance with Rule 461 promulgated by the Commission pursuant to the Securities
Act, within five Trading Days of the date that the Company is notified (orally or in writing, whichever is earlier) by the Commission
that such Registration Statement will not be “reviewed” or will not be subject to further review, or (iii) prior to
the effective date of a Registration Statement, the Company fails to file a pre-effective amendment and otherwise respond in writing
to comments made by the Commission in respect of such Registration Statement within 15 Trading Days after the receipt of comments
by or notice from the Commission that such amendment is required in order for such Registration Statement to be declared effective,
or (iv) a Registration Statement registering for resale all of the Registrable Securities is not declared effective by the Commission
by the Effectiveness Date of the Initial Registration Statement, or (v) after the effective date of a Registration Statement, such
Registration Statement ceases for any reason to remain continuously effective as to all Registrable Securities included in such
Registration Statement, or the Holders are otherwise not permitted to utilize the Prospectus therein to resell such Registrable
Securities, for more than ten (10) consecutive Trading Days or more than an aggregate of fifteen (15) Trading Days (which need
not be consecutive calendar days) during any 12-month period (any such failure or breach being referred to as an “Event”,
and for purposes of clauses (i) and (iv), the date on which such Event occurs, and for purpose of clause (ii) the date on which
such five (5) Trading Day period is exceeded, and for purpose of clause (iii) the date which such fifteen (15) Trading Day period
is exceeded, and for purpose of clause (v) the date on which such ten (10) or fifteen (15) Trading Day period, as applicable, is
exceeded being referred to as “Event Date”), then, in addition to any other rights the Holders may have hereunder
or under applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event
shall not have been cured by such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in
cash, as partial liquidated damages and not as a penalty, equal to 1.0% of the aggregate purchase price paid by such Holder pursuant
to the Purchase Agreement. If the Company fails to pay any partial liquidated damages pursuant to this Section in full within seven
days after the date payable, the Company will pay interest thereon at a rate of 12% per annum (or such lesser maximum amount that
is permitted to be paid by applicable law) to the Holder, accruing daily from the date such partial liquidated damages are due
until such amounts, plus all such interest thereon, are paid in full. The partial liquidated damages pursuant to the terms hereof
shall apply on a daily pro rata basis for any portion of a month prior to the cure of an Event. Notwithstanding anything to the
contrary contained herein, (A) no liquidated damages shall be payable by the Company in connection with any Event if the Registrable
Securities may be resold pursuant to Rule 144, and, if requested by the Transfer Agent, the Company’s counsel has issued
the opinion described in Section 4.1(c) of the Purchase Agreement, (B) the maximum payment to a Holder associated with all Events
in the aggregate shall not exceed (1) in any monthly period, an aggregate of 1.0% of the aggregate purchase price paid by such
Holder pursuant to the Purchase Agreement for its Registrable Securities (plus accrued interest thereon, if applicable) and (2)
10% of the aggregate purchase price paid by such Holder pursuant to the Purchase Agreement for its Registrable Securities, and
(C) no liquidated damages shall be payable by the Company with respect to Registrable Securities that the Company is not permitted
to register as a secondary offering, but subject to the Company’s obligations as described in Section 2(b).

 

    	 	6	 

     

    

 

(e)          If
Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register
the resale of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities
on Form S-3 as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration
Statement then in effect until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared
effective by the Commission. Each Holder hereby acknowledges and understands that, as of the date of this Agreement, the Company
is not eligible to use Form S-3.

 

(f)          Notwithstanding
anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate of a Holder
as any Underwriter without the prior written consent of such Holder.

 

(g)          Notwithstanding
anything to the contrary contained herein, the Company may elect, in its sole discretion, to pay any liquidated damages required
by Section 2(d) in cash, shares of Common Stock (“Liquidated Damages Shares”) or any combination thereof; provided,
however, that the Company may not elect to issue Liquidated Damage Shares to a Holder pursuant to this Section 2(f) to the
extent that such Holder’s beneficial ownership (as determined in accordance with Section 13(d) of the Exchange Act) of Common
Stock would exceed [4].99% after giving effect to the issuance of Liquidated Damages Shares to such Holder (but not any other Holders
hereunder), and, in such case, shall only pay the liquidated damages in cash. If electing to issue Liquidated Damages Shares, the
Company shall, on or before the applicable deadline for payment pursuant to Section 2(d), deliver or cause to be delivered to each
Holder: (A) a certificate or certificates representing the number of Liquidated Damages Shares issued to such Holder in payment
of liquidated damages, and (B) a certificate setting forth (i) the aggregate amount of liquidated damages owed to such Holder,
and (ii) the quotient equal to (x) the portion of such aggregate amount that the Company is electing to pay to such Holder in Liquidated
Damages Shares in lieu of cash, divided by (y) $0.35 (subject to appropriate adjustment hereafter for stock splits, combinations
and similar recapitalization events), which quotient, rounded to the nearest whole number, shall represent the number of Liquidated
Damages Shares issued to such Holder.

 

3.             Registration
Procedures.

 

In connection with
the Company’s registration obligations hereunder, the Company shall:

 

(a)          Not
less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior
to the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated
or deemed to be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed
to be filed, which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review
of such Holders, and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to
such inquiries as shall be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation
within the meaning of the Securities Act. Notwithstanding the above, the Company shall not be obligated to provide the Holders
advance copies of any universal shelf registration statement registering securities in addition to those required hereunder, or
any Prospectus prepared thereto. The Company shall not file a Registration Statement or any such Prospectus or any amendments or
supplements thereto to which the Holders of two-thirds or more of the Registrable Securities shall reasonably object in good faith,
provided that, the Company is notified of such objection in writing no later than five (5) Trading Days after the Holders have
been so furnished copies of a Registration Statement or one (1) Trading Day after the Holders have been so furnished copies of
any related Prospectus or amendments or supplements thereto. Each Holder agrees to furnish to the Company a completed questionnaire
in the form attached to this Agreement as Annex B (a “Selling Stockholder Questionnaire”) on a date that
is not less than two (2) Trading Days prior to the Filing Date or by the end of the fourth (4th) Trading Day following
the date on which such Holder receives draft materials in accordance with this Section.

 

    	 	7	 

     

    

 

(b)          (i)
Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the
Prospectus used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable
Registrable Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements
in order to register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to
be amended or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented
or amended, to be filed pursuant to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the
Commission with respect to a Registration Statement or any amendment thereto and provide as promptly as reasonably possible to
the Holders true and complete copies of all correspondence from and to the Commission relating to a Registration Statement (provided
that, the Company shall excise any information contained therein which would constitute material non-public information regarding
the Company or any of its Subsidiaries), and (iv) comply in all material respects with the applicable provisions of the Securities
Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by a Registration Statement during
the applicable period in accordance (subject to the terms of this Agreement) with the intended methods of disposition by the Holders
thereof set forth in such Registration Statement as so amended or in such Prospectus as so supplemented.

 

(c)          If
during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common
Stock then registered in a Registration Statement, then to the extent permitted by the Securities Act (including the rules and
regulations thereunder) or SEC Guidance, the Company shall file as soon as reasonably practicable, but in any case prior to the
applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of
such Registrable Securities.

 

    	 	8	 

     

    

 

(d)          Notify
the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied
by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible
(and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person)
confirm such notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement
or post-effective amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether
there will be a “review” of such Registration Statement and whenever the Commission comments in writing on such Registration
Statement, and (C) with respect to a Registration Statement or any post-effective amendment, when the same has become effective,
(ii) of any request by the Commission or any other federal or state governmental authority for amendments or supplements to a Registration
Statement or Prospectus or for additional information, (iii) of the issuance by the Commission or any other federal or state governmental
authority of any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities
or the initiation of any Proceedings for that purpose, (iv) of the receipt by the Company of any notification with respect to the
suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction,
or the initiation or threatening of any Proceeding for such purpose, (v) of the occurrence of any event or passage of time that
makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement made in a
Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any
material respect or that requires any revisions to a Registration Statement, Prospectus or other documents so that, in the case
of a Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact
or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading, and (vi) of the occurrence or existence of any pending corporate development with respect
to the Company that the Company believes may be material and that, in the determination of the Company, makes it not in the best
interest of the Company to allow continued availability of a Registration Statement or Prospectus, provided, however,
in no event shall any such notice contain any information which would constitute material, non-public information regarding the
Company or any of its Subsidiaries.

 

(e)          Use
its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness
of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable
Securities for sale in any jurisdiction, at the earliest practicable moment.

 

    	 	9	 

     

    

 

(f)          Furnish
to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including
financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent
requested by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated
by reference) promptly after the filing of such documents with the Commission; provided, that any such item which is available
on the EDGAR system (or successor thereto) need not be furnished in physical form.

 

(g)          Subject
to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto
by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus
and any amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).

 

(h)          The
Company shall cooperate with any broker-dealer through which a Holder proposes to resell its Registrable Securities in effecting
a filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110, as requested by any such Holder, and the Company
shall pay the filing fee required by such filing within two (2) Business Days of request therefor.

 

(i)          Prior
to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate
with the selling Holders in connection with the registration or qualification (or exemption from the Registration or qualification)
of such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within
the United States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom)
effective during the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition
in such jurisdictions of the Registrable Securities covered by each Registration Statement; provided, that, the Company shall not
be required to qualify generally to do business in any jurisdiction where it is not then so qualified, subject the Company to any
material tax in any such jurisdiction where it is not then so subject or file a general consent to service of process in any such
jurisdiction.

 

(j)          If
requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing
Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free,
to the extent permitted by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be
in such denominations and registered in such names as any such Holder may request.

 

(k)          Upon
the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into
account the Company’s good faith assessment of any adverse consequences to the Company and its stockholders of the premature
disclosure of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement
or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file
any other required document so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain
an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they were made, not misleading. If
the Company notifies the Holders in accordance with clauses (iii) through (vi) of Section 3(d) above to suspend the use of any
Prospectus until the requisite changes to such Prospectus have been made, then the Holders shall suspend use of such Prospectus.
The Company will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The
Company shall be entitled to exercise its right under this Section 3(k) to suspend the availability of a Registration Statement
and Prospectus, subject to the payment of partial liquidated damages otherwise required pursuant to Section 2(d), for a period
not to exceed 60 calendar days (which need not be consecutive days) in any 12-month period.

 

    	 	10	 

     

    

 

(l)          Comply
with all applicable rules and regulations of the Commission.

 

(m)        The
Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock
beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive
control over the shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration
of the Registrable Securities solely because any Holder fails to furnish such information within three Trading Days of the Company’s
request, any liquidated damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise
occur solely because of such delay shall be suspended as to such Holder only, until such information is delivered to the Company.

 

(n)          With
respect to any Registration Statement involving an underwritten offering, if requested by the Holders, the Company shall use its
reasonable best efforts to obtain legal opinion letters and negative assurances statements (and updates thereof) from its counsel
and “comfort” letters (and updates thereof) from the independent certified public accountants of the Company (and,
if necessary, any other independent certified public accountants of any subsidiary of the Company or of any business acquired by
the Company for which financial statements and financial data are, or are required to be, included in, or incorporated by reference
into, a Registration Statement), addressed to each selling Holder of Registrable Shares included in a Registration Statement and
the underwriters, if any, in customary form and covering such matters of the kind customarily covered by such letters and statements
in transactions of the nature contemplated by such Registration Statement.

 

    	 	11	 

     

    

 

4.             Registration
Expenses. All fees and expenses incident to the performance of or compliance with, this Agreement by the Company shall be borne
by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred
to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation,
fees and expenses of the Company’s counsel and independent registered public accountants) (A) with respect to filings made
with the Commission, (B) with respect to filings required to be made with any Trading Market on which the Common Stock is then
listed for trading, (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in
writing (including, without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications
or exemptions of the Registrable Securities) and (D) if not previously paid by the Company in connection with an issuer filing,
with respect to any filing that may be required to be made by any broker through which a Holder intends to make sales of Registrable
Securities with FINRA pursuant to FINRA Rule 5110, so long as the broker is receiving no more than a customary brokerage commission
in connection with such sale, (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable
Securities), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities
Act liability insurance, if the Company so desires such insurance, (vi) fees and expenses of all other Persons retained by the
Company in connection with the consummation of the transactions contemplated by this Agreement, (vii) and the reasonable fees and
disbursements with respect to the review of the Registration Statement, not to exceed $5,000, of one counsel for the selling Holders,
and (viii) to the extent Registrable Securities are not then covered by an effective Registration Statement, the reasonable out-of-pocket
costs and expenses incurred by a Holder related to the resale of such Registrable Securities by such Holder under Rule 144 (but
excluding broker fees or similar commissions incurred by such Holder). In addition, the Company shall be responsible for all of
its internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including,
without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense
of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities
exchange as required hereunder. In no event shall the Company be responsible for any broker or similar commissions of any Holder
or, except to the extent provided for in the Transaction Documents, any legal fees or other costs of the Holders.

 

5.             Indemnification.

 

(a)          Indemnification
by the Company. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder,
the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities as principal
as a result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees (and
any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or
any other title) of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and
any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or
any other title) of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all
losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys’ fees) and expenses (collectively,
“Losses”), as incurred, arising out of or relating to (1) any untrue or alleged untrue statement of a material
fact contained in a Registration Statement, any Prospectus or any form of prospectus or in any amendment or supplement thereto
or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required
to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light
of the circumstances under which they were made) not misleading or (2) any violation or alleged violation by the Company of the
Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the performance
of its obligations under this Agreement, except to the extent, but only to the extent, that (i) such untrue statements or omissions
are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein,
or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable
Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement, such
Prospectus or in any amendment or supplement thereto (it being understood that the Holder has approved Annex A hereto for this
purpose) or (ii) in the case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi), the use by such Holder
of an outdated, defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus
is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated
in Section 6(d), but only if and to the extent that following the receipt of the Advice the misstatement or omission giving rise
to such Loss would have been corrected. The Company shall notify the Holders promptly of the institution, threat or assertion of
any Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is aware.
Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified person
and shall survive the transfer of any Registrable Securities by any of the Holders in accordance with Section 6(h).

 

    	 	12	 

     

    

 

(b)          Indemnification
by Holders. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers,
agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section
20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted
by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: (x) such Holder’s
failure to comply with any applicable prospectus delivery requirements of the Securities Act through no fault of the Company; or
(y) any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any
amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission
of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or
supplement thereto, in light of the circumstances under which they were made) not misleading (i) to the extent, but only to the
extent, that such untrue statement or omission is contained in any information so furnished in writing by such Holder to the Company
expressly for inclusion in such Registration Statement or such Prospectus or (ii) to the extent, but only to the extent, that such
information relates to such Holder’s proposed method of distribution of Registrable Securities and was reviewed and expressly
approved in writing by such Holder expressly for use in a Registration Statement (it being understood that the Holder has approved
Annex A hereto for this purpose), such Prospectus or in any amendment or supplement thereto or (iii) in the case of an occurrence
of an event of the type specified in Section 3(d)(iii)-(vi), to the extent, but only to the extent, related to the use by such
Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing that
the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of
the Advice contemplated in Section 6(d), but only if and to the extent that following the receipt of the Advice the misstatement
or omission giving rise to such Loss would have been corrected. In no event shall the liability of any selling Holder under this
Section 3(b) be greater in amount than the dollar amount of the net proceeds received by such Holder upon the sale of the Registrable
Securities giving rise to such indemnification obligation.

 

(c)          Conduct
of Indemnification Proceedings. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder
(an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity is sought
(the “Indemnifying Party”) in writing, and the Indemnifying Party shall have the right to assume the defense
thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses
incurred in connection with defense thereof; provided, that, the failure of any Indemnified Party to give such notice shall not
relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that
it shall be finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review)
that such failure shall have materially and adversely prejudiced the Indemnifying Party.

 

An Indemnified
Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the
fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party
has agreed in writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense
of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named
parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party,
and counsel to the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same
counsel were to represent such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies
the Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying
Party shall not have the right to assume the defense thereof and the reasonable fees and expenses of no more than one separate
counsel shall be at the expense of the Indemnifying Party). The Indemnifying Party shall not be liable for any settlement of any
such Proceeding effected without its written consent, which consent shall not be unreasonably withheld or delayed. No Indemnifying
Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect
of which any Indemnified Party is a party, unless such settlement includes an unconditional release of such Indemnified Party from
all liability on claims that are the subject matter of such Proceeding.

 

    	 	13	 

     

    

 

Subject to
the terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses
to the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with
this Section) shall be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying
Party; provided, that, the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and
expenses applicable to such actions for which such Indemnified Party is finally determined by a court of competent jurisdiction
(which determination is not subject to appeal or further review) not to be entitled to indemnification hereunder.

 

(d)          Contribution.
If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold an Indemnified
Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified
Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection
with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations.
The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether
any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of
a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party,
and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement
or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations
set forth in this Agreement, any reasonable attorneys’ or other fees or expenses incurred by such party in connection with
any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for
in this Section was available to such party in accordance with its terms.

 

    	 	14	 

     

    

 

The parties
hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata
allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the
immediately preceding paragraph. Notwithstanding the provisions of this Section 5(d), no Holder shall be required to contribute
pursuant to this Section 5(d), in the aggregate, any amount in excess of the amount by which the net proceeds actually received
by such Holder from the sale of the Registrable Securities subject to the Proceeding exceeds the amount of any damages that such
Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.

 

The indemnity
and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to
the Indemnified Parties.

 

6.             Miscellaneous.

 

(a)          Remedies.
In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement, each Holder
or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement,
including recovery of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company
and each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach
by it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance
in respect of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.

 

(b)          No
Piggyback on Registrations; Prohibition on Filing Other Registration Statements. Neither the Company nor any of its security
holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration Statements
other than the Registrable Securities. Other than with respect to registration statements filed on Forms S-4 and S-8 or those required
to be filed pursuant to the 2012 Registration Rights Agreement, the Company shall not file any other registration statements until
all Registrable Securities are registered pursuant to a Registration Statement that is declared effective by the Commission; provided,
however, that this Section 6(b) shall not prohibit the Company from filing amendments to registration statements filed prior
to the date of this Agreement; and provided further, however, that in the event the Commission limits the
number of Registrable Securities that may be registered by the initial Registration Statement in accordance with Section 2(b),
above, then for purposes of this sentence the prohibition against filing other registration statements shall not apply following
the effectiveness of such initial Registration Statement.

 

(c)          Compliance.
Each Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable
to it (unless an exemption therefrom is available) in connection with sales of Registrable Securities pursuant to a Registration
Statement.

 

    	 	15	 

     

    

 

(d)          Discontinued
Disposition. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company
of the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue
disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the “Advice”)
by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company
will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees
and acknowledges that any period during which the Holder is required to discontinue the disposition of the Registrable Securities
hereunder shall be subject to the provisions of Section 2(d).

 

(e)          Piggy-Back
Registrations. Subject to Sections 2(b) and 2(c) hereof, if at any time during the Effectiveness Period, there is not an effective
Registration Statement covering all of the Registrable Securities and the Company shall determine to prepare and file with the
Commission a registration statement relating to an offering for its own account or the account of others under the Securities Act
of any of its equity securities, other than on Form S-4 or Form S-8 (each as promulgated under the Securities Act) or their then
equivalents relating to equity securities to be issued solely in connection with any acquisition of any entity or business or equity
securities issuable in connection with the Company’s stock option or other employee benefit plans or the 2012 Registration
Rights Agreement, then the Company shall deliver to each Holder a written notice of such determination and, if within fifteen days
after the date of the delivery of such notice, any such Holder shall so request in writing, the Company shall include in such registration
statement all or any part of such Registrable Securities such Holder requests to be registered; provided, however,
that the Company shall not be required to register any Registrable Securities pursuant to this Section 6(e) that are eligible for
resale pursuant to Rule 144 (without volume restrictions or current public information requirements) promulgated by the Commission
pursuant to the Securities Act or that are the subject of a then effective Registration Statement.

 

(f)           Rule
144 Reporting. With a view to making available to the Holders the benefits of Rule 144, the Company agrees after the date hereof
to:

 

(i)          make
and keep public information available, as those terms are understood and defined in Rule 144(c) under the Securities Act;

 

(ii)         file
with the Commission all reports and other documents required of the Company under the Securities Act and the Exchange Act; and

 

(iii)        so
long as a Holder owns any Registrable Securities, to furnish to such Holder forthwith upon request a written statement by the Company
as to its compliance with the reporting requirements of said Rule 144, and of the Securities Act and the Exchange Act, a copy of
the most recent annual or quarterly report of the Company, and such other reports and documents so filed by the Company as the
Holder may reasonably request in writing in complying with any rule or regulation of the SEC allowing the Holder to sell any such
securities without registration.

 

    	 	16	 

     

    

 

(g)          Amendments
and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented,
and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed
by the Company and the Holders of at least two-thirds of the then outstanding Registrable Securities (for purposes of clarification,
this includes any Registrable Securities issuable upon exercise or conversion of any Security). If a Registration Statement does
not register all of the Registrable Securities pursuant to a waiver or amendment done in compliance with the previous sentence,
then the number of Registrable Securities to be registered for each Holder shall be reduced pro rata among all Holders and each
Holder shall have the right to designate which of its Registrable Securities shall be omitted from such Registration Statement.
Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively
to the rights of a Holder or some Holders and that does not directly or indirectly affect the rights of other Holders may be given
only by such Holder or Holders of all of the Registrable Securities to which such waiver or consent relates; provided, however,
that the provisions of this sentence may not be amended, modified, or supplemented except in accordance with the provisions of
the first sentence of this Section 6(f). No consideration shall be offered or paid to any Person to amend or consent to a waiver
or modification of any provision of this Agreement unless the same consideration also is offered to all of the parties to this
Agreement.

 

(h)          Notices.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as
set forth in the Purchase Agreement.

 

(i)           Successors
and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each
of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations
hereunder without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may
assign their respective rights hereunder in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.

 

(j)           No
Inconsistent Agreements. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the
Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities,
that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions
hereof. Except as set forth on Schedule 6(i), neither the Company nor any of its Subsidiaries has previously entered into
any agreement granting any registration rights with respect to any of its securities to any Person that have not been satisfied
in full.

 

    	 	17	 

     

    

 

(k)          Execution
and Counterparts. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other
party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by
facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and
binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if
such facsimile or “.pdf” signature page were an original thereof.

 

(l)           Governing
Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined
in accordance with the provisions of the Purchase Agreement.

 

(m)          Cumulative
Remedies. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.

 

(n)          Severability.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full
force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that
they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.

 

(o)          Headings.
The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be deemed to limit
or affect any of the provisions hereof.

 

    	 	18	 

     

    

 

(p)          Independent
Nature of Holders’ Obligations and Rights. The obligations of each Holder hereunder are several and not joint with the
obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations
of any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no
action taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association,
a joint venture or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert
or as a group or entity with respect to such obligations or the transactions contemplated by this Agreement or any other matters,
and the Company acknowledges that the Holders are not acting in concert or as a group, and the Company shall not asset any such
claim, with respect to such obligations or transactions. Each Holder shall be entitled to protect and enforce its rights, including
without limitation the rights arising out of this Agreement, and it shall not be necessary for any other Holder to be joined as
an additional party in any proceeding for such purpose. The use of a single agreement with respect to the obligations of the Company
contained was solely in the control of the Company, not the action or decision of any Holder, and was done solely for the convenience
of the Company and not because it was required or requested to do so by any Holder. It is expressly understood and agreed that
each provision contained in this Agreement is between the Company and a Holder, solely, and not between the Company and the Holders
collectively and not between and among Holders.

 

********************

 

(Signature
Pages Follow)

 

    	 	19	 

     

    

 

IN WITNESS WHEREOF,
the parties have executed this Registration Rights Agreement as of the date first written above.

 

	 	ARNO THERAPEUTICS, INC.
	 	 
	 	By:	 
	 	 	Name:  
	 	 	Title:

 

[SIGNATURE PAGES OF HOLDERS FOLLOW]

 

     

     

    

 

[SIGNATURE
PAGE OF HOLDERS TO ARNI RRA]

 

 

	Name of Holder:	 	 

 

	Signature of Authorized Signatory of Holder:	 	 

 

	Name of Authorized Signatory:	 	 

 

	Title of Authorized Signatory:	 	 

 

[SIGNATURE PAGES CONTINUE]

 

     

     

    

 

Annex A

 

Plan of Distribution

 

Each Selling Stockholder
(the “Selling Stockholders”) of the securities and any of their pledgees, assignees and successors-in-interest
may, from time to time, sell any or all of their securities covered hereby on the principal Trading Market or any other stock exchange,
market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated
prices. A Selling Stockholder may use any one or more of the following methods when selling securities:

 

		·	ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

 

		·	block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion
of the block as principal to facilitate the transaction;

 

		·	purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

 

		·	an exchange distribution in accordance with the rules of the applicable exchange;

 

		·	privately negotiated transactions;

 

		·	settlement of short sales entered into after the effective date of the registration statement of which this prospectus is a
part;

 

		·	in transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities
at a stipulated price per security;

 

		·	through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;

 

		·	a combination of any such methods of sale; or

 

		·	any other method permitted pursuant to applicable law.

 

The Selling Stockholders
may also sell securities under Rule 144 under the Securities Act of 1933, as amended (the “Securities Act”),
if available, rather than under this prospectus.

 

     

     

    

 

Broker-dealers engaged
by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser)
in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction
not in excess of a customary brokerage commission in compliance with FINRA Rule 2440; and in the case of a principal transaction
a markup or markdown in compliance with FINRA IM-2440.

 

In connection with
the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions
they assume. The Selling Stockholders may also sell securities short and deliver these securities to close out their short positions,
or loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter
into option or other transactions with broker-dealers or other financial institutions or create one or more derivative securities
which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which
securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended
to reflect such transaction).

 

The Selling Stockholders
and any broker-dealers or agents that are involved in selling the securities may be deemed to be “underwriters” within
the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement
or understanding, directly or indirectly, with any person to distribute the securities. In no event shall any broker-dealer receive
fees, commissions and markups which, in the aggregate, would exceed eight percent (8%).

 

The Company is required
to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed
to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the
Securities Act.

 

Because Selling Stockholders
may be deemed to be “underwriters” within the meaning of the Securities Act, they will be subject to the prospectus
delivery requirements of the Securities Act including Rule 172 thereunder. In addition, any securities covered by this prospectus
which qualify for sale pursuant to Rule 144 under the Securities Act may be sold under Rule 144 rather than under this prospectus.
The Selling Stockholders have advised us that there is no underwriter or coordinating broker acting in connection with the proposed
sale of the resale securities by the Selling Stockholders.

 

    	 	2	 

     

    

 

We agreed to keep this
prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders without
registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for
the Company to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of
similar effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or
any other rule of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if
required under applicable state securities laws. In addition, in certain states, the resale securities covered hereby may not be
sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification
requirement is available and is complied with.

 

Under applicable rules
and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously
engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation
M, prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions
of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and
sales of securities of the common stock by the Selling Stockholders or any other person. We will make copies of this prospectus
available to the Selling Stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser
at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).

 

    	 	3	 

     

    

 

Annex B

 

ARNO
THERAPEUTICS, INC.

 

Selling Stockholder Notice and Questionnaire

 

The undersigned beneficial
owner of common stock (the “Registrable Securities”) of ARNO THERAPEUTICS, INC., a Delaware corporation (the
“Company”), understands that the Company has filed or intends to file with the Securities and Exchange Commission
(the “Commission”) a registration statement (the “Registration Statement”) for the registration
and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable
Securities, in accordance with the terms of the Registration Rights Agreement (the “Registration Rights Agreement”)
to which this document is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the
address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration
Rights Agreement.

 

Certain legal consequences
arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly, holders
and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences
of being named or not being named as a selling stockholder in the Registration Statement and the related prospectus.

 

NOTICE

 

The undersigned beneficial
owner (the “Selling Stockholder”) of Registrable Securities hereby elects to include the Registrable Securities
owned by it in the Registration Statement.

 

Please fax a copy (or email a .pdf copy)
of this completed and executed Notice and Questionnaire to:

 

Christopher J. Melsha, Esq.

Fredrikson & Byron, P.A.

200 South Sixth Street, Suite 4000

Minneapolis, MN 55402

Fax: (612) 492-7077

Email: cmelsha@fredlaw.comc

 

     

     

    

 

The undersigned hereby provides the following
information to the Company and represents and warrants that such information is accurate:

 

QUESTIONNAIRE

 

	1.	Name.

 

	 	(a)	Full Legal Name of Selling Stockholder
	 	 	 
	 	 	 

 

	 	(b)	Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities are held:
	 	 	 
	 	 	 

 

	 	(c)	Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered by this Questionnaire):
	 	 	 
	 	 	 

 

2. Address for Notices to Selling
Stockholder:

 

	 
	 
	 
	Telephone:	 

 

	Fax:	 

 

	Contact Person:	 

 

     

     

    

 

3. Broker-Dealer Status:

 

	 	(a)	Are you a broker-dealer?

 

Yes  ̈         No
 ̈

 

	 	(b)	If “yes” to Section 3(a), did you receive your Registrable Securities as compensation for investment banking services to the Company?

 

Yes  ̈         No
 ̈

 

	 	Note:	If “no” to Section 3(b), the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

	 	(c)	Are you an affiliate of a broker-dealer?

 

Yes  ̈         No
 ̈

 

	 	(d)	If you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?

 

Yes  ̈         No
 ̈

 

	 	Note:	If “no” to Section 3(d), the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

4. Beneficial Ownership of Securities
of the Company Owned by the Selling Stockholder.

 

Except as set forth below
in this Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than the securities
issuable pursuant to the Purchase Agreement.

 

	 	(a)	Type and Amount of other securities beneficially owned by the Selling Stockholder:
	 	 	 
	 	 	 
	 	 	 

 

     

     

    

 

5. Relationships with the Company:

 

Except as set forth below,
neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the
equity securities of the undersigned) has held any position or office or has had any other material relationship with the Company
(or its predecessors or affiliates) during the past three years.

 

	 	State any exceptions here:
	 	 
	 	 
	 	 
	 	 

 

The undersigned agrees
to promptly notify the Company of any inaccuracies or changes in the information provided herein that may occur subsequent to the
date hereof at any time while the Registration Statement remains effective.

 

By
signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through
5 and the inclusion of such information in the Registration Statement and the related prospectus and any amendments or supplements
thereto. The undersigned understands that such information will be relied upon by the Company in
connection with the preparation or amendment of the Registration Statement and the related prospectus and any amendments or supplements
thereto.

 

IN WITNESS WHEREOF
the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person
or by its duly authorized agent.

 

	Date:  	 	 	Beneficial Owner:	 

 

	 	 	By:	 
	 	 	 	Name:
	 	 	 	Title:SUBSCRIPTION AGREEMENT

SUBSCRIPTION AGREEMENT
(this “Agreement”) made as of the last date set forth on the signature page hereof between ID Global Solutions Corporation
a Delaware corporation (the “Company”), and the undersigned (the “Subscriber”).

W I T N E S S E T H:

WHEREAS, the Company
is conducting a private offering (the “Offering”) consisting of up to 20,000,000 shares (the “Shares”)
of common stock, $0.0001 par value per share (“Common Stock”), pursuant to Section 4(2) of the Securities Act of 1933,
as amended (the “Securities Act”) and Rule 506 promulgated thereunder; and

WHEREAS, the Subscriber
desires to purchase that number of Shares set forth on the signature page hereof on the terms and conditions hereinafter set forth.

NOW, THEREFORE, in
consideration of the premises and the mutual representations and covenants hereinafter set forth, the parties hereto do hereby
agree as follows:

		I.	SUBSCRIPTION FOR SHARES AND REPRESENTATIONS BY SUBSCRIBER

1.1             
Subject to the terms and conditions hereinafter set forth, the Subscriber hereby irrevocably subscribes for and agrees to
purchase from the Company such number of Shares, and the Company agrees to sell to the Subscriber as is set forth on the signature
page hereof, at a per share price equal to $0.05 per Share. The purchase price is payable by wire transfer of immediately available
funds or check payable to the Company to the Company pursuant to the wire instructions set forth on Schedule 1.1.

 

1.2             
The Subscriber recognizes that the purchase of the Shares involves a high degree of risk including, but not limited to,
the following: (a) the Company has limited operating history and requires substantial funds in addition to the proceeds of the
Offering; (b) an investment in the Company is highly speculative, and only investors who can afford the loss of their entire investment
should consider investing in the Company and the Shares; (c) the Subscriber may not be able to liquidate its investment; (d) transferability
of the Shares is extremely limited; (e) in the event of a disposition, the Subscriber could sustain the loss of its entire investment;
(f) the Company has not paid any dividends since its inception and does not anticipate paying any dividends; (g) the Company may
issue additional securities in the future which have rights and preferences that are senior to those of the Common Stock and (h)
the Company is not presently current in its filings under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
Without limiting the generality of the representations set forth in Section 1.5 below, the Subscriber represents that the Subscriber
has carefully reviewed the risk factors described in the Company's filings made under the Exchange Act.

1.3             
The Subscriber represents that the Subscriber is an “accredited investor” as such term is defined in Rule 501
of Regulation D (“Regulation D”) promulgated under the Securities Act, as indicated by the Subscriber’s responses
to the questions contained in Article VI hereof, and that the Subscriber is able to bear the economic risk of an investment in
the Shares.

    

     

    

 

1.4             
The Subscriber hereby acknowledges and represents that (a) the Subscriber has knowledge and experience in business and financial
matters, prior investment experience, including investment in securities that are non-listed, unregistered and/or not traded on
a national securities exchange nor on the NASDAQ, or the Subscriber has employed the services of a “purchaser representative”
(as defined in Rule 501 of Regulation D), attorney and/or accountant to read all of the documents furnished or made available by
the Company both to the Subscriber and to all other prospective investors in the Shares to evaluate the merits and risks of such
an investment on the Subscriber’s behalf; (b) the Subscriber recognizes the highly speculative nature of this investment;
and (c) the Subscriber is able to bear the economic risk that the Subscriber hereby assumes.

1.5             
The Subscriber hereby acknowledges receipt and careful review of this Agreement, including all exhibits thereto, and any
documents which may have been made available upon request as reflected therein (collectively referred to as the “Offering
Materials”) and hereby represents that the Subscriber has been furnished by the Company during the course of the Offering
with all information regarding the Company, the terms and conditions of the Offering and any additional information that the Subscriber
has requested or desired to know, and has been afforded the opportunity to ask questions of and receive answers from duly authorized
officers or other representatives of the Company concerning the Company and the terms and conditions of the Offering.

1.6             
(a)In making the decision to invest in the Shares the Subscriber has relied solely upon the information provided by
the Company in the Offering Materials. To the extent necessary, the Subscriber has retained, at its own expense, and relied upon
appropriate professional advice regarding the investment, tax and legal merits and consequences of this Agreement and the purchase
of the Shares hereunder. The Subscriber disclaims reliance on any statements made or information provided by any person or entity
in the course of Subscriber’s consideration of an investment in the Shares other than the Offering Materials.

(b)The Subscriber
represents that (i) the Subscriber was contacted regarding the sale of the Shares by the Company (or an authorized agent or representative
thereof) with whom the Subscriber had a prior substantial pre-existing relationship and (ii) no Shares were offered or sold to
it by means of any form of general solicitation or general advertising, and in connection therewith, the Subscriber did not (A)
receive or review any advertisement, article, notice or other communication published in a newspaper or magazine or similar media
or broadcast over television or radio, whether closed circuit, or generally available; or (B) attend any seminar meeting or industry
investor conference whose attendees were invited by any general solicitation or general advertising.

1.7             
The Subscriber hereby represents that the Subscriber, either by reason of the Subscriber’s business or financial experience
or the business or financial experience of the Subscriber’s professional advisors (who are unaffiliated with and not compensated
by the Company or any affiliate or selling agent of the Company, directly or indirectly), has the capacity to protect the Subscriber’s
own interests in connection with the transaction contemplated hereby.

    

     

    

 

1.8             
The Subscriber hereby acknowledges that the Offering has not been reviewed by the United States Securities and Exchange
Commission (the “SEC”) nor any state regulatory authority since the Offering is intended to be exempt from the registration
requirements of Section 5 of the Securities Act, pursuant to Regulation D. The Subscriber understands that the Shares have not
been registered under the Securities Act or under any state securities or “blue sky” laws and agrees not to sell, pledge,
assign or otherwise transfer or dispose of the Shares unless they are registered under the Securities Act and under any applicable
state securities or “blue sky” laws or unless an exemption from such registration is available.

1.9             
The Subscriber understands that the Shares have not been registered under the Securities Act by reason of a claimed exemption
under the provisions of the Securities Act that depends, in part, upon the Subscriber’s investment intention. In this connection,
the Subscriber hereby represents that the Subscriber is purchasing the Shares for the Subscriber’s own account for investment
and not with a view toward the resale or distribution to others. The Subscriber, if an entity, further represents that it was not
formed for the purpose of purchasing the Shares.

1.10         
The Subscriber understands that the common stock issuable upon conversion of the Common Stock is quoted on the OTC Markets
and that there is a limited market for the Common Stock. The Subscriber understands that even if a public market develops for the
Common Stock, Rule 144 (“Rule 144”) promulgated under the Securities Act requires for non-affiliates, among other conditions,
a holding period prior to the resale (in limited amounts) of securities acquired in a non-public offering without having to satisfy
the registration requirements under the Securities Act. The Subscriber understands and hereby acknowledges that the Company is
under no obligation to register any of the Shares under the Securities Act or any state securities or “blue sky” laws.
The Subscriber understands that the Company must be current under the 1934 Act for the Subscriber to take advantage of Rule 144.
The Subscriber acknowledges that the Company is not current under the 1934 Act.

1.11         
The Subscriber consents to the placement of a legend on any certificate or other document evidencing the Shares and any
shares of common stock issuable upon conversion of the Common Stock that such securities have not been registered under the Securities
Act or any state securities or “blue sky” laws and setting forth or referring to the restrictions on transferability
and sale thereof contained in this Agreement. The Subscriber is aware that the Company will make a notation in its appropriate
records with respect to the restrictions on the transferability of such Shares. The legend to be placed on each certificate shall
be in form substantially similar to the following:

“THE SECURITIES REPRESENTED HEREBY
HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY STATE SECURITIES
OR “BLUE SKY LAWS,” AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED ABSENT AN EFFECTIVE
REGISTRATION THEREOF UNDER SUCH ACT OR COMPLIANCE WITH RULE 144 PROMULGATED UNDER SUCH ACT, OR UNLESS THE COMPANY HAS RECEIVED
AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.”

1.12         
The Subscriber understands that the Company will review this Agreement and is hereby given authority by the Subscriber to
call Subscriber’s bank or place of employment or otherwise review the financial standing of the Subscriber; and it is further
agreed that the Company, at its sole discretion, reserves the unrestricted right, without further documentation or agreement on
the part of the Subscriber, to reject or limit any subscription, to accept subscriptions for fractional Shares and to close the
Offering to the Subscriber at any time and that the Company will issue stop transfer instructions to its transfer agent with respect
to such Shares.

    

     

    

 

1.13         
The Subscriber hereby represents that the address of the Subscriber furnished by Subscriber on the signature page hereof
is the Subscriber’s principal residence if Subscriber is an individual or its principal business address if it is a corporation
or other entity.

1.14         
The Subscriber represents that the Subscriber has full power and authority (corporate, statutory and otherwise) to execute
and deliver this Agreement and to purchase the Shares. This Agreement constitutes the legal, valid and binding obligation of the
Subscriber, enforceable against the Subscriber in accordance with its terms.

1.15         
If the Subscriber is a corporation, partnership, limited liability company, trust, employee benefit plan, individual retirement
account, Keogh Plan, or other tax-exempt entity, it is authorized and qualified to invest in the Company and the person signing
this Agreement on behalf of such entity has been duly authorized by such entity to do so.

1.16         
The Subscriber acknowledges that he, she or it are not Registered Representative of an Finra member firm or an Finra firm.

1.17         
The Subscriber acknowledges that at such time, if ever, as the Shares are registered, sales of the Shares will be subject
to state securities laws.

1.18         
(a)The Subscriber agrees not to issue any public statement with respect to the Subscriber’s investment or proposed
investment in the Company or the terms of any agreement or covenant between them and the Company without the Company’s prior
written consent, except such disclosures as may be required under applicable law or under any applicable order, rule or regulation.

(b)              
The Company agrees not to disclose the names, addresses or any other information about the Subscribers, except as required
by law; provided, that the Company may use the name of the Subscriber for any offering or in any registration statement filed.

1.19         
Brokers. The Subscriber acknowledges that the Company has engaged Network 1 Financial Securities, Inc., a broker
dealer registered with FINRA (“Network”), as a finder in connection with the sale of the Common Stock and Network shall
be entitled to a fee equal to eight (8%) percent of the gross proceeds and shares of Common Stock of the Company equal to the aggregate
principal amount of the Common Stock multiplied by eight (8%) percent, which product is divided by $0.05.

    

     

    

 

1.20         
The Subscriber agrees to hold the Company and its directors, officers, employees, affiliates, controlling persons and agents
and their respective heirs, representatives, successors and assigns harmless and to indemnify them against all liabilities, costs
and expenses incurred by them as a result of (a) any sale or distribution of the Shares by the Subscriber in violation of the Securities
Act or any applicable state securities or “blue sky” laws; or (b) any false representation or warranty or any breach
or failure by the Subscriber to comply with any covenant made by the Subscriber in this Agreement (including the Confidential Investor
Questionnaire contained in Article VI herein) or any other document furnished by the Subscriber to any of the foregoing in connection
with this transaction.

1.21          The Subscriber
acknowledges that the Company in its sole discretion may increase the number of Shares sold in this Offering from 20,000,000
Shares to 26,000,000 resulting in the Offering increasing from $1,000,000 to $1,300,000.

 

		II.	REPRESENTATIONS BY AND COVENANTS OF THE COMPANY

 

The Company hereby
represents and warrants to the Subscriber that:

2.1             
Organization and Qualification. The Company and each of its Subsidiaries, if any, is a corporation duly organized,
validly existing and in good standing under the laws of the jurisdiction in which it is incorporated, with full power and authority
(corporate and other) to own, lease, use and operate its properties and to carry on its business as and where now owned, leased,
used, operated and conducted. “Subsidiary” shall mean any corporation or other entity of which at least a majority
of the securities or other ownership interests having ordinary voting power (absolutely or contingently) for the election of directors
or other persons performing similar functions are at the time owned directly or indirectly by the Company and/or any of its other
Subsidiaries.

2.2             
Capitalization. The capitalization of the Company is as set forth on Schedule 2.2 attached hereto. The authorized,
issued and outstanding capital stock of the Company is as set forth in the reports, schedules, forms, statements and other documents
required to be filed by it with the SEC pursuant to the reporting requirements of the Exchange Act, including material filed pursuant
to Section 13(a) or 15(d) of the Exchange Act (all of the foregoing including filings incorporated by reference therein being referred
to herein as the “Commission Documents”).

2.3             
Authorization; Enforcement. The Company has all requisite corporate power and authority to enter into and perform
this Agreement.

2.4             
Acknowledgment of Dilution. The Company understands and acknowledges the dilutive effect to the Common Stock upon
the issuance of the Shares.

2.5             
Bad Actor Representation. None of the Company, any of its predecessors, any affiliated issuer, any director,
executive officer, other officer of the Company participating in the Offering, any beneficial owner of 20% or more of the Company’s
outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule
405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an “Issuer Covered Person”
and, together, “Issuer Covered Persons”) is subject to any of the “Bad Actor” disqualifications described
in Rule 506(d)(1)(i) to (viii) under the Securities Act (a “Disqualification Event”), except for a Disqualification
Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person
is subject to a Disqualification Event.

    

     

    

 

2.6             
Shell Company Status. During the previous twelve (12) months, the Company has not been a shell as such term is defined
in Rule 144(i) under the Securities Act.

2.7             
Commission Documents, Financial Statements. Except for the Company’s Form 10-K Annual Report for the year
ended December 31, 2015, the amended Form 8-K disclosing the financial statements for Multipay, S.A., the amended Form 8-K disclosing
the financial statements for Fin Holdings, Inc., the Company's Form 10-Q for the quarter ended March 31, 2016, the Company has
filed all Commission Documents.

2.8             
No Material Adverse Effect. Since March 31, 2015, neither the Company, nor any Subsidiary has experienced or suffered
any Material Adverse Effect. For the purposes of this Agreement, “Material Adverse Effect” means any of (i)
a material and adverse effect on the legality, validity or enforceability of this Agreement or the other Offering Materials, (ii)
a material adverse effect on the business, operations, properties, or financial condition of the Company, its Subsidiaries, individually,
or in the aggregate and/or any condition, circumstance, or situation that would prohibit or otherwise materially interfere with
the ability of the Company to perform any of its obligations under this Agreement or the other Offering Materials in any material
respect or (iii) an adverse impairment to the Company’s ability to perform on a timely basis its obligations under this Agreement
or the other Transaction Document.

2.9             
No Undisclosed Liabilities. Other than as disclosed in the Commission Documents, to the knowledge of the Company,
neither the Company, nor any Subsidiary has any liabilities, obligations, claims or losses (whether liquidated or unliquidated,
secured or unsecured, absolute, accrued, contingent or otherwise) other than those incurred in the ordinary course of the Company’s
and any Subsidiary’s respective businesses since September 30, 2014 and those which, individually or in the aggregate, do
not have a Material Adverse Effect on the Company and any Subsidiary.

2.10         
No Undisclosed Events or Circumstances. To the Company’s knowledge, no event or circumstance has occurred or
exists with respect to the Company or any Subsidiary or their respective businesses, properties, operations or financial condition,
which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been
so publicly announced or disclosed.

2.11         
Indebtedness. Other than as set forth on Schedule 2.11, the Financial Statements set forth all outstanding
secured and unsecured Indebtedness of the Company, or for which the Company, or any Subsidiary have commitments as of the date
of the Financial Statements or any subsequent period that would require disclosure. For the purposes of this Agreement, “Indebtedness”
shall mean (a) any liabilities for borrowed money or amounts owed (other than trade accounts payable incurred in the ordinary course
of business), (b) all guaranties, endorsements and other contingent obligations in respect of Indebtedness of others, whether or
not the same should be reflected in the Company’s consolidated balance sheet (or the Securities thereto), except guaranties
by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business;
and (c) the present value of any lease payments due under leases required to be capitalized in accordance with GAAP. Neither the
Company, nor any Subsidiary is in default with respect to any Indebtedness which, individually or in the aggregate, would have
a Material Adverse Effect.

    

     

    

2.12         
Actions Pending. Except as disclosed in the Commission Documents, there is no action, suit, claim, investigation,
arbitration, alternate dispute resolution proceeding or any other proceeding pending or, to the knowledge of the Company, threatened
against or involving the Company, any Subsidiary (i) which questions the validity of this Agreement or any of the other Offering
Materials or the transactions contemplated hereby or thereby or any action taken or to be taken pursuant hereto or thereto or (ii)
involving any of their respective properties or assets. To the knowledge of the Company, there are no outstanding orders, judgments,
injunctions, awards or decrees of any court, arbitrator or governmental or regulatory body against the Company or any Subsidiary
or any of their respective executive officers or directors in their capacities as such.

2.13         
Compliance with Law. The Company and its Subsidiaries have all material franchises, permits, licenses, consents and
other governmental or regulatory authorizations and approvals necessary for the conduct of their respective business as now being
conducted by it unless the failure to possess such franchises, permits, licenses, consents and other governmental or regulatory
authorizations and approvals, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect.

2.14         
Compliance. The Company: (i) is not in default under or in violation of (and no event has occurred that has not been
waived that, with notice or lapse of time or both, would result in a default by the Company), nor has the Company received notice
of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement
or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation
has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority
or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without
limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety,
product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to
result in a Material Adverse Effect.

2.15         
No Violation. The business of the Company and any Subsidiary is not being conducted in violation of any federal,
state, local or foreign governmental laws, or rules, regulations and ordinances of any governmental entity, except for possible
violations which singularly or in the aggregate could not reasonably be expected to have a Material Adverse Effect. The Company
is not required under federal, state, local or foreign law, rule or regulation to obtain any consent, authorization or order of,
or make any filing or registration with, any court or governmental agency in order for it to execute, deliver or perform any of
its obligations under the Offering Materials, or issue and sell the Common Stock in accordance with the terms hereof or thereof
(other than (x) any consent, authorization or order that has been obtained as of the date hereof, (y) any filing or registration
that has been made as of the date hereof or (z) any filings which may be required to be made by the Company with the SEC or state
securities administrators subsequent to each closing).

    

     

    

2.16         
No Conflicts. The execution, delivery and performance of this Agreement and the Offering Materials by the Company
and the consummation by the Company of the transactions contemplated herein and therein do not and will not (i) violate any provision
of the Articles or Bylaws, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both
would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement,
mortgage, deed of trust, indenture, note, bond, license, lease agreement, instrument or obligation to which the Company or any
Subsidiary is a party or by which it or its properties or assets are bound, (iii) create or impose a lien, mortgage, security interest,
pledge, charge or encumbrance (collectively, “Lien”) of any nature on any property of the Company or any Subsidiary
under any agreement or any commitment to which the Company or any Subsidiary is a party or by which the Company, or any Subsidiary
is bound or by which any of its respective properties or assets are bound, or (iv) result in a violation of any federal, state,
local or foreign statute, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations)
applicable to the Company or any Subsidiary or by which any property or asset of the Company, or any Subsidiary are bound or affected,
provided, however, that, excluded from the foregoing in all cases are such conflicts, defaults, terminations, amendments,
accelerations, cancellations and violations as would not, individually or in the aggregate, have a Material Adverse Effect.

2.17         
Taxes. Each of the Company and any Subsidiary, to the extent its applicable, has accurately prepared and filed all
federal, state and other tax returns required by law to be filed by it, has paid or made provisions for the payment of all taxes
shown to be due other than payment being contested and all additional assessments, and adequate provisions have been and are reflected
in the consolidated financial statements of the Company for all current taxes and other charges to which the Company, or any Subsidiary,
if any, is subject and which are not currently due and payable. None of the federal income tax returns of the Company have been
audited by the Internal Revenue Service. The Company has no knowledge of any additional assessments, adjustments or contingent
tax liability (whether federal, state or foreign) of any nature whatsoever, whether pending or threatened against the Company or
any Subsidiary for any period, nor of any basis for any such assessment, adjustment or contingency.

2.18         
Licenses. Except as otherwise set forth in the Commission Documents, the Company has sufficient licenses, permits
and other governmental authorizations currently required for the conduct of its business or ownership of properties and is in all
material respects in compliance therewith.

2.19         
Litigation. There is no action, suit, proceeding, or investigation (including without limitation any suit, proceeding,
or investigation involving the prior employment of any of the Company’s employees, their use in connection with the Company’s
business of any information or techniques allegedly proprietary to any of their former employers, or their obligations under any
agreements with prior employers) pending or, to the best of the Company’s knowledge, currently threatened before any court,
administrative agency, or other governmental body. The Company is not a party or subject to, and none of its assets is bound by,
the provisions of any order, writ, injunction, judgment, or decree of any court or government agency or instrumentality. There
is no action, suit, or proceeding by the Company currently pending or that the Company intends to initiate.

    

     

    

2.20         
Disclosure. The Company has fully provided each Subscriber with all the information that such Subscriber has requested
for deciding whether to purchase the Common Stock and all material information that the Company believes is reasonably necessary
to enable a reasonable Subscriber to make such decision. Neither this Agreement, nor any other agreements, statements or certificates
made or delivered to Subscriber in connection herewith or therewith contains any untrue statement of a material fact or, when taken
together, omits to state a material fact necessary to make the statements herein or therein, in light of the circumstances under
which they were made, not misleading.

2.21         
Books and Records Internal Accounting Controls. Except as may have otherwise been disclosed in the Commission Documents,
the books and records of the Company, and any Subsidiary accurately reflect in all material respects the information relating to
the business of the Company and any Subsidiary, the location and collection of their assets, and the nature of all transactions
giving rise to the obligations or accounts receivable of the Company, or any Subsidiary. The Company and any Subsidiary maintain
a system of internal accounting controls sufficient, in the judgment of the Company, to provide reasonable assurance that (i) transactions
are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary
to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets
is permitted only in accordance with management’s general or specific authorization and (iv) the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate actions are taken with respect to any differences.

2.22         
Material Agreements. Any and all written or oral contracts, instruments, agreements, commitments, obligations, plans
or arrangements, the Company and any Subsidiary is a party to, that a copy of which would be required to be filed with the SEC
as an exhibit to a registration statement (collectively, the “Material Agreements”) if the Company or any Subsidiary
were registering securities under the Securities Act has previously been publicly filed with the SEC in the Commission Documents.
Each of the Company and any Subsidiary has in all material respects performed all the obligations required to be performed by them
to date under the foregoing agreements, have received no notice of default and are not in default under any Material Agreement
now in effect the result of which would cause a Material Adverse Effect.

    

     

    

 

2.23         
Transactions with Affiliates. Except as set forth in the Financial Statements, in the Commission Documents or on
Schedule 2.23, there are no loans, leases, agreements, contracts, royalty agreements, management contracts or arrangements
or other continuing transactions between (a) the Company, or any Subsidiary on the one hand, and (b) on the other hand, any officer,
employee, consultant or director of the Company or any Subsidiary, or any person owning more than 10% capital stock of the Company,
or any Subsidiary, or any member of the immediate family of such officer, employee, consultant, director or stockholder or any
corporation or other entity controlled by such officer, employee, consultant, director or stockholder, or a member of the immediate
family of such officer, employee, consultant, director or stockholder.

2.24         
Private Placement and Solicitation. Assuming the accuracy of the Subscribers’ representations and warranties
set forth in Section 1, no registration under the Securities Act is required for the offer and sale of the Common Stock by the
Company to the Subscribers as contemplated hereby. Based in part on the accuracy of the representations of the Subscribers in Section
1, and subject to timely applicable Form D filings pursuant to Regulation D of the Securities Act with the SEC and pursuant to
applicable state securities laws, the offer, sale and issuance of the Common Stock to be issued pursuant to and in conformity with
the terms of this Agreement, will be issued in compliance with all applicable federal and state securities laws. Neither the Company
nor any of its affiliates, nor any person acting on its or their behalf, has engaged in any form of general solicitation or general
advertising (within the meaning of Regulation D under the Securities Act) in connection with the offer or sale of any of the Common
Stock.

2.25         
Governmental Approvals. Except for the filing of any notice prior or subsequent to each closing that may be required
under applicable state and/or federal securities laws (which if required, shall be filed on a timely basis), including the filing
of a Form D, no authorization, consent, approval, license, exemption of, filing or registration with any court or governmental
department, commission, board, bureau, agency or instrumentality, domestic or foreign, is or will be necessary for, or in connection
with, the execution or delivery of the Common Stock, or for the performance by the Company of its obligations under this Agreement
and the Offering Materials.

2.26         
Employees. The Company does not have a collective bargaining arrangements covering any of its employees. A list of
the employment contracts, agreements regarding proprietary information, non-competition agreements, non-solicitation agreements,
confidentiality agreement, or any other similar contract or restrictive covenant, relating to the right of any officer, employee
or consultant to be employed or engaged by the Company is set forth in the Commission Documents. Since March 31, 2015, no officer,
consultant or key employee of the Company or any Subsidiary whose termination, either individually or in the aggregate, would have
a Material Adverse Effect, has terminated or, to the knowledge of the Company, has any present intention of terminating his or
her employment or engagement with the Company or any Subsidiary.

2.27         
Investment Company. The Company is not an “investment company” within the meaning of such term under
the Investment Company Act of 1940, as amended, and the rules and regulations of the SEC thereunder.

2.28         
Intellectual Property. Each of the Company and any Subsidiary, owns or has the lawful right to use all patents, trademarks,
domain names (whether or not registered) and any patentable improvements or copyrightable derivative works thereof, websites and
intellectual property rights relating thereto, service marks, trade names, copyrights, licenses and authorizations, if any, and
all rights with respect to the foregoing, if any, which are necessary for the conduct of their respective business as now conducted
without any conflict with the rights of others, except where the failure to so own or possess would not have a Material Adverse
Effect.

    

     

    

 

2.29         
Title to Assets. Except as set forth on Schedule 2.29, the Company has good and marketable title in fee simple
to all real property owned by it and good and marketable title in all personal property owned by it that is material to the business
of the Company, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property
and do not materially interfere with the use made and proposed to be made of such property by the Company and (ii) Liens for the
payment of federal, state or other taxes, for which appropriate reserves have been made therefore in accordance with GAAP and,
the payment of which is neither delinquent nor subject to penalties (liens referenced in subsection (i) and (ii) above are collectively
referred to as "Permitted Liens"). Any real property and facilities held under lease by the Company are held by it under
valid, subsisting and enforceable leases with which the Company is in compliance.

2.30         
Blue Sky Laws. The Company shall take such action as the Company shall reasonably determine is necessary to qualify
the Common Stock for sale to the Subscribers at the applicable closing pursuant to this Agreement under applicable securities or
“blue sky” laws of the states of the United States (or to obtain an exemption from such qualification), and shall provide
evidence of any such action so taken to each Subscriber.

2.31         
Use of Proceeds. The Company shall use the proceeds from the sale of the Common Stock for working capital
purposes and shall not, directly or indirectly, use such proceeds for any distribution or dividend to any shareholder of the Company.

2.32         
Securities Compliance. The Company shall notify the SEC in accordance with its rules and regulations, of the transactions
contemplated by this Agreement and the Offering Materials, including filing a Form D with respect to the Common Stock, as required
under Regulation D and applicable “blue sky” laws if such Common Stock is offered pursuant to Rule 506 of Regulation
D and shall take all other necessary action and proceedings as may be required and permitted by applicable law, rule and regulation,
for the legal and valid issuance of the Common Stock to the Subscribers.

2.33         
Liquidation. Subject to the terms of the Offering Materials, the Company covenants that it will take such further
action as the Subscribers may reasonably request, all to the extent required from time to time to enable the Subscribers to sell
the Common Stock without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated
under the Securities Act, as amended.

2.34         
Keeping of Records and Books of Account. The Company shall keep and cause each Subsidiary to keep adequate records
and books of account, in which complete entries will be made in accordance with GAAP consistently applied, reflecting all financial
transactions of the Company and its Subsidiaries, and in which, for each fiscal year, all proper reserves for depreciation, depletion,
obsolescence, amortization, taxes, bad debts and other purposes in connection with its business shall be made.

2.35         
Intentionally left blank.

 

    

     

    

 

2.36         
Other Agreements. The Company shall not and shall cause its Subsidiaries, enter into any agreement the terms of which
would restrict or impair the ability of the Company to perform its obligations under this Agreement and the Offering Materials.

2.37         
Reporting Status. So long as a Subscriber beneficially owns any of the Common Stock, the Company shall timely file
all reports required to be filed with the SEC pursuant to the Exchange Act, and the Company shall not terminate its status as an
issuer required to file reports under the Exchange Act even if the Exchange Act or the rules and regulations thereunder would permit
such termination.

2.38         
Disclosure of Transaction. The Company shall file with the SEC, a Current Report on Form 8-K describing the material
terms of the transactions contemplated hereby and all material non-public information disclosed to the Subscribers prior to the
filing as soon as practicable after each closing but in no event later than 5:30 P.M. (EDT) on the fourth Business Day following
each closing. In the event that the Company is unable to disclose specific non-public information in the Form 8-K, the Company
shall include such information in its Form 10-Q for the interim period during which the closing contemplated hereby occurs. “Business
Day” means any day during which the NASDAQ (or other principal exchange)
shall be open for trading.

2.39         
Sarbanes-Oxley Act. The Company shall be in compliance with the applicable provisions of the Sarbanes-Oxley Act of
2002, and the rules and regulations promulgated thereunder, as required under such Act.

2.40         
No Integrated Offerings. The Company shall not make any offers or sales of any security (other than the securities
being offered or sold hereunder) under circumstances that would require registration of the securities being offered or sold hereunder
under the Securities Act.

		III.	TERMS OF SUBSCRIPTION

3.1             
All funds shall be submitted directly to the Company’s account identified in Schedule 1.1 hereof.

3.2             
Certificates representing the Common Stock purchased by the Subscriber pursuant to this Agreement will be prepared for delivery
to the Subscriber within 15 business days following the closing, the timing of which is at the Company’s sole discretion,
at which such purchase takes place. The Subscriber hereby authorizes and directs the Company to deliver the certificates representing
the Common Stock purchased by the Subscriber pursuant to this Agreement directly to the Subscriber’s residential or business
address indicated on the signature page hereto.

 

    

     

    

		IV.	CONDITIONS TO OBLIGATIONS OF THE SUBSCRIBERS

 

4.1             
The Subscriber’s obligation to purchase the Shares at the closing at which such purchase is to be consummated is subject
to the fulfillment on or prior to such closing of the following conditions, which conditions may be waived at the option of each
Subscriber to the extent permitted by law:

(a)               
Covenants. All covenants, agreements and conditions contained in this Agreement to be performed by the Company on
or prior to the date of such closing shall have been performed or complied with in all material respects.

(b)              
No Legal Order Pending. There shall not then be in effect any legal or other order enjoining or restraining the transactions
contemplated by this Agreement.

(c)               
No Law Prohibiting or Restricting Such Sale. There shall not be in effect any law, rule or regulation prohibiting
or restricting such sale or requiring any consent or approval of any person, which shall not have been obtained, to issue the Shares
(except as otherwise provided in this Agreement).

		V.	MISCELLANEOUS

5.1             
Any notice or other communication given hereunder shall be deemed sufficient if in writing and sent by registered or certified
mail, return receipt requested, or delivered by hand against written receipt therefor, addressed as follows:

if to the
Company, to it at:

	ID Global Solutions Corporation
	160 East Brantley Drive
	Longwood, FL 32779
	Attention: Thomas R. Szoke
	Telephone: (407) 951-8640
	Facsimile:  

 

 

if to the Subscriber, to the Subscriber’s
address indicated on the signature page of this Agreement.

Notices shall be deemed to have been
given or delivered on the date of mailing, except notices of change of address, which shall be deemed to have been given or delivered
when received.

5.2             
Except as otherwise provided herein, this Agreement shall not be changed, modified or amended except by a writing signed
by the parties to be charged, and this Agreement may not be discharged except by performance in accordance with its terms or by
a writing signed by the party to be charged.

5.3             
Subject to the provisions of Section 5.10, this Agreement shall be binding upon and inure to the benefit of the parties
hereto and to their respective heirs, legal representatives, successors and assigns. This Agreement sets forth the entire agreement
and understanding between the parties as to the subject matter hereof and merges and supersedes all prior discussions, agreements
and understandings of any and every nature among them.

    

     

    

 

5.4             
Upon the execution and delivery of this Agreement by the Subscriber, this Agreement shall become a binding obligation of
the Subscriber with respect to the purchase of Shares as herein provided, subject, however, to the right hereby reserved by the
Company to enter into the same agreements with other subscribers and to add and/or delete other persons as subscribers.

5.5             
NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY AGREE
THAT ALL THE TERMS AND PROVISIONS HEREOF SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF FLORIDA
WITHOUT REGARD TO SUCH STATE’S PRINCIPLES OF CONFLICTS OF LAW. IN THE EVENT THAT A JUDICIAL PROCEEDING IS NECESSARY, THE
SOLE FORUM FOR RESOLVING DISPUTES ARISING OUT OF OR RELATING TO THIS AGREEMENT IS THE COURTS STATE OF FLORIDA IN AND FOR THE COUNTY
OF SEMINOLE OR THE FEDERAL COURTS FOR SUCH STATE AND COUNTY, AND ALL RELATED APPELLATE COURTS, THE PARTIES HEREBY IRREVOCABLY CONSENT
TO THE JURISDICTION OF SUCH COURTS AND AGREE TO SAID VENUE.

5.6             
In order to discourage frivolous claims the parties agree that unless a claimant in any proceeding arising out of this Agreement
succeeds in establishing his claim and recovering a judgment against another party (regardless of whether such claimant succeeds
against one of the other parties to the action), then the other party shall be entitled to recover from such claimant all of its/their
reasonable legal costs and expenses relating to such proceeding and/or incurred in preparation therefor.

5.7             
The holding of any provision of this Agreement to be invalid or unenforceable by a court of competent jurisdiction shall
not affect any other provision of this Agreement, which shall remain in full force and effect. If any provision of this Agreement
shall be declared by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced in whole or in part,
such provision shall be interpreted so as to remain enforceable to the maximum extent permissible consistent with applicable law
and the remaining conditions and provisions or portions thereof shall nevertheless remain in full force and effect and enforceable
to the extent they are valid, legal and enforceable, and no provisions shall be deemed dependent upon any other covenant or provision
unless so expressed herein.

5.8             
It is agreed that a waiver by either party of a breach of any provision of this Agreement shall not operate, or be construed,
as a waiver of any subsequent breach by that same party.

5.9             
The parties agree to execute and deliver all such further documents, agreements and instruments and take such other and
further action as may be necessary or appropriate to carry out the purposes and intent of this Agreement.

    

     

    

 

5.10         
This Agreement may be executed in two or more counterparts each of which shall be deemed an original, but all of which shall
together constitute one and the same instrument.

5.11         
Nothing in this Agreement shall create or be deemed to create any rights in any person or entity not a party to this Agreement.

 

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

 

    

     

    

 

 

		VI.       CONFIDENTIAL	INVESTOR QUESTIONNAIRE

 

6.1             
The Subscriber represents and warrants that he, she or it comes within one category marked below, and that for any category
marked, he, she or it has truthfully set forth, where applicable, the factual basis or reason the Subscriber comes within that
category. ALL INFORMATION IN RESPONSE TO THIS SECTION WILL BE KEPT STRICTLY CONFIDENTIAL. The undersigned agrees to furnish any
additional information which the Company deems necessary in order to verify the answers set forth below.

Category A 
                       The undersigned is an individual (not a partnership, corporation, etc.) whose individual net worth, or joint net worth
with his or her spouse, presently exceeds $1,000,000.

 

Explanation. In calculating net worth
you may include equity in personal property and real estate (excluding your principal residence), cash, short-term investments,
stock and securities. Equity in personal property and real estate should be based on the fair market value of such property less
debt secured by such property.

 

Category B 
                        The undersigned is an individual (not a partnership, corporation, etc.) who had an income in excess of $200,000 in each
of the two most recent years, or joint income with his or her spouse in excess of $300,000 in each of those years (in each case
including foreign income, tax exempt income and full amount of capital gains and losses but excluding any income of other family
members and any unrealized capital appreciation) and has a reasonable expectation of reaching the same income level in the current
year.

 

Category C 
                        The undersigned is a director or executive officer of the Company which is issuing and selling the Shares.

 

Category
D                       The undersigned is a bank; a savings and loan association; insurance company; registered investment company; registered
business development company; licensed small business investment company (“SBIC”); or employee benefit plan within
the meaning of Title 1 of ERISA and (a) the investment decision is made by a plan fiduciary which is either a bank, savings and
loan association, insurance company or registered investment advisor, or (b) the plan has total assets in excess of $5,000,000
or (c) is a self directed plan with investment decisions made solely by persons that are accredited investors. (describe entity)

 

 

 

Category
E                          The undersigned is a private business development company as defined in section 202(a) (22) of the Investment Advisors
Act of 1940. (describe entity)

    

     

    

 

 

 

Category
F                          The undersigned is either a corporation, partnership, Massachusetts business trust, or non-profit organization within
the meaning of Section 501(c) (3) of the Internal Revenue Code, in each case not formed for the specific purpose of acquiring the
Shares and with total assets in excess of $5,000,000. (describe entity)

 

 

Category
G                         The undersigned is a trust with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring
the Shares, where the purchase is directed by a “sophisticated investor” as defined in Regulation 506(b)(2)(ii) under
the Act.

 

Category
H                         The undersigned is an entity (other than a trust) in which all of the equity owners are “accredited investors”
within one or more of the above categories. If relying upon this Category alone, each equity owner must complete a separate copy
of this Agreement. (describe entity)

________________________________________________________________

________________________________________________________________

 

Category
I                          The undersigned is not within any of the categories above and is therefore not an accredited investor.

The undersigned agrees that the
undersigned will notify the Company at any time on or prior to the closing in the event that the representations and warranties
in this Agreement shall cease to be true, accurate and complete.

6.2             
SUITABILITY (please answer each question)

(a)          For an individual
Subscriber, please describe your current employment, including the company by which you are employed and its principal business:

 

 

    ________________________________________________________________________________

    ________________________________________________________________________________

 

(b)            For an
individual Subscriber, please describe any college or graduate degrees held by you:

 

 

    ________________________________________________________________________________

    ________________________________________________________________________________

(c)             For all Subscribers,
please list types of prior investments:

 

    ________________________________________________________________________________

    ________________________________________________________________________________

 

    

     

    

 

(d)             For all Subscribers,
please state whether you have participated in other private placements before:

YES_______NO_______

(e)If your answer
to question (d) above was “YES”, please indicate frequency of such prior participation in private placements
of:

	 	
         

        Public

        Companies
	
         

        Private

        Companies
	
        Public or Private Companies

        with no, or insignificant,

        assets and operations

         

	Frequently			
	Occasionally			
	Never			

 

(f)For individual
Subscribers, do you expect your current level of income to significantly decrease in the foreseeable future:

YES_______NO_______

(g)For trust,
corporate, partnership and other institutional Subscribers, do you expect your total assets to significantly decrease in the foreseeable
future:

YES_______NO_______

(h)For all Subscribers,
do you have any other investments or contingent liabilities which you reasonably anticipate could cause you to need sudden cash
requirements in excess of cash readily available to you:

YES_______NO_______

(i)For all Subscribers,
are you familiar with the risk aspects and the non-liquidity of investments such as the securities for which you seek to subscribe?

YES_______NO_______

(j) For all
Subscribers, do you understand that there is no guarantee of financial return on this investment and that you run the risk of losing
your entire investment?

YES_______NO_______

6.3             
MANNER IN WHICH TITLE IS TO BE HELD. (circle one)

(a)Individual Ownership

(b)Community Property

(c)Joint Tenant
with Right of

      Survivorship
(both parties

      must sign)

(d)Partnership*

(e)Tenants in Common

(f)Company*

(g)Trust*

(h)Other*

    

     

    

 

*If Securities are
being subscribed for by an entity, the attached Certificate of Signatory must also be completed.

6.4             
The undersigned is informed of the significance to the Company of the foregoing representations and answers contained in
the Confidential Investor Questionnaire contained in this Article VI and such answers have been provided under the assumption that
the Company will rely on them.

6.4

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

 

    

     

    

 

 

 

 

 

 

NUMBER OF SHARES _________ X $0.05 = $_________
(the “Purchase Price”)

 

 

Signature                                                          Signature
(if purchasing jointly)

 

Name Typed or Printed                                  Name Typed or Printed

 

Title (if Subscriber is an
Entity)             
      Title (if Subscriber is an Entity)

 

_________________________
 

Entity Name (if applicable)                              Entity Name
(if applicable

 

Address                                                              Address

 

City, State and Zip Code                                  City, State and
Zip Code

 

Telephone-Business                                         Telephone-Business

 

 

Telephone-Residence                                       Telephone-Residence

 

 

Facsimile-Business                                            Facsimile-Business

 

 

Facsimile-Residence                                          Facsimile-Residence

 

 

Tax ID # or Social Security #                            Tax
ID # or Social Security #

Name in which securities should be issued:

 

 

Dated: , 2016

 

This Subscription
Agreement is agreed to and accepted as of ________________ , 2016.

ID GLOBAL SOLUTIONS
CORPORATION

 

 

By:____________________________________

 

Name:
Thomas R. Szoke

Title:Chief Executive
Officer

 

    

     

    

CERTIFICATE OF SIGNATORY

 

(To be completed if Securities are

being subscribed for by an entity)

 

 

I, ____________________________, am the ____________________________
of

 

__________________________________________
(the “Entity”).

 

I certify that I am empowered and duly authorized
by the Entity to execute and carry out the terms of the Subscription Agreement and to purchase and hold the shares of Common Stock,
and certify further that the Subscription Agreement has been duly and validly executed on behalf of the Entity and constitutes
a legal and binding obligation of the Entity.

 

IN WITNESS WHEREOF, I have set my hand this
________ day of _________________, 2016

 

 

_______________________________________

(Signature)

 

    

     

    

 

SCHEDULES TO SECURITIES PURCHASE AGREEMENT

 

Schedule 1.1

 

Account Name:ID Global Solutions Corporation

Account #:898065076223           
                  

ABA #:026009593     

Bank:Bank of America       

Address:2601 State Road 434 W

Longwood,
FL 32779 US                    

 

Schedule 2.2 Capitalization                   

 

 

	Shares Outstanding	214,196,550
	Affiliate Warrants & Options	58,550,000
	Non-Affiliated Warrants & Options	1,978,622
	Convertible Debentures	32,408,436
	Warrants ($.05 – Convertible Debentures Raise - I)	19,580,000
	Warrants ($.15 – Convertible Debentures Raise - II)	7,733,873
	Warrants ($.15 – Convertible Debentures Raise - III)	1,902,001
	Warrants ($.48 – Convertible Debentures Raise - IV)	2,120,000
	Warrants ($.10 – Convertible Debentures Raise - V)	31,53,667
	Parity Labs Stock Options	20,000,000
	New Retention Based Option Grants	10,500,000
	New Performance Based Option Grants	             6,500,000 
	 	 
	Fully Diluted	407,023,148

 

Schedule 2.11 – Indebtedness

 

On April 19, 2016, the Company entered into
and closed Securities Purchase Agreements with several accredited investors (the "April 2016 Accredited Investors") pursuant
to which the April 2016 Accredited Investors invested an aggregate of $1,550,000 into the Company in consideration of Secured Convertible
Debentures and common stock purchase warrants to acquire an aggregate of 15,500,000 shares of common stock exercisable for a period
of five years at an exercise price of $0.10 subject to antidilution protection, as amended. The exercise price shall be adjusted
to equal the conversion price or the per share purchase price of Company's next offering in the minimum amount of $5,000,000 (the
"Adjustment Price") and the number of shares of common stock issuable upon exercise of the warrants shall be adjusted
to equal the consideration paid by the April 2016 Accredited Investors by the Adjustment Price. The Secured Convertible Debentures
bear interest of 12% and are payable on the six (6) month anniversary of the Secured Convertible Debentures. The Secured Convertible
Debentures are convertible into shares of common stock at $0.10 per share, as amended, subject to antidilution protection. The
conversion price shall be adjusted to equal the Adjustment Price less a 20% discount if such Adjustment Price is less than $0.25
per share. The Secured Convertible Debentures are secured by 18,235,295 issued and outstanding shares of common stock of the Company
held by certain shareholders of the Company (the "Pledgors") pursuant to stock pledge agreements entered into between
the April 2016 Accredited Investors and the Pledgors. Each of the April 2016 Accredited Investors have
individually agreed to restrict their ability to convert the Secured Convertible Debentures or exercise their Common Stock Purchase
Warrants and receive shares of common stock such that the number of shares of common stock held by them and their affiliates
after such conversion or exercise does not exceed 4.99% of the then issued and outstanding shares of common stock.

 

    

     

    

 

 

On December 22 through December 28, 2015, the
Company entered into and closed Securities Purchase Agreements with several accredited investors (the "2015 Accredited Investors")
pursuant to which the 2015 Accredited Investors invested $850,000 (the "Offering") into the Company in consideration
of Promissory Notes (the "Notes") and common stock purchase warrants (the "Warrants") to acquire an aggregate
of 1,770,832 shares of common stock. The Warrants are exercisable for a period of five years at an exercise price of $0.48. The
Notes bear interest of 12% and are payable one year from the date of issuance. The Notes are secured by pro-rata pledges of 10,000,000
issued and outstanding shares of common stock of the Company held by the Company's Chief Executive Officer, Thomas R. Szoke, pursuant
to stock pledge agreements entered into between the 2015 Accredited Investors and Mr. Szoke. Prior to the maturity dates of the
Notes, the 2015 Accredited Investors may elect to convert the interest accrued on the Notes into shares of common stock of the
Company at a conversion rate of $0.48 per share (the “Interest Conversion Price”), provided, however, that upon the
closing of the next financing following the closing of the Offering in which the Company sells shares of common stock or securities
that are convertible into shares of common stock in excess of $5,000,000 (the "Subsequent Financing"), the Interest Conversion
Price will be adjusted to equal such price per share or conversion price utilized in such Subsequent Financing, provided, however,
that in no event will the Interest Conversion Price be increased and such adjustment to the Interest Conversion Price will be a
one-time event.

 

On September 25, 2015 through November 5, 2015,
the Company entered into and closed Securities Purchase Agreements with several accredited investors (the "2015 Accredited
Investors") pursuant to which the 2015 Accredited Investors invested $1,250,000 (the "Offering") into the Company
in consideration of Secured Promissory Notes (the "Notes") and common stock purchase warrants (the "Warrants")
to acquire an aggregate of 8,333,338 shares of common stock. The Warrants are exercisable for a period of five years at an exercise
price of $0.15. The Notes bear interest of 12% and are payable one year from the date of issuance. The Notes are secured by 100%
of the Company’s interest in ID Global LATAM S.A.S., a wholly-owned Colombian subsidiary of the Company. Prior to the maturity
dates of the Notes, the 2015 Accredited Investors may elect to convert the interest accrued on the Notes into shares of common
stock of the Company at a conversion rate of $0.10 per share.

 

On September 4, 2015, ID the Company entered
into a Securities Purchase Agreement with Ricky Solomon, a director of the Company, pursuant to which Mr. Solomon invested $100,000
into the Company in consideration of a Secured Promissory Note (the "Solomon Note") and a common stock purchase warrant
to acquire an aggregate of 250,000 shares of common stock exercisable for a period of five years at an exercise price of $0.40.
The Solomon Note bears interest of 10%, is payable on the earlier of the Company closing a financing in excess of $1,000,000 or
on September 19, 2015. The Solomon Note contains standard default terms and is secured by all assets of the Company. In the event
the Company defaults under the Note, the Company is required to issue Mr. Solomon an additional common stock purchase warrant to
acquire 666,667 shares of common stock at $0.15 per share.

 

From June 25, 2015 through June 30, 2015, the
Company entered into and closed Securities Purchase Agreements with several accredited investors pursuant to which the accredited
investors invested $700,000 (the "First Closing") into the Company in consideration of Secured Convertible Debentures
and common stock purchase warrants to acquire an aggregate of 15,400,000 shares of common stock. On July 29, 2015, the Company
entered into and closed Securities Purchase Agreements with several accredited investors pursuant to which the accredited investors
invested $190,000 (the "Second Closing” and together with the First Closing, the “Offering") into the Company
in consideration of Secured Convertible Debentures and common stock purchase warrants to acquire an aggregate of 4,180,000 shares
of common stock. The warrants are exercisable for a period of five years at an exercise price of $0.05 subject to antidilution
protection.

    

     

    

 

 

The Secured Convertible Debentures bear interest
of 10%, are payable on the earlier of the Company closing a financing in excess of $2,000,000 or one year from the date of issuance.
The Secured Convertible Debentures are convertible into shares of common stock at $0.03 per share subject to antidilution protection.
In the event the Secured Convertible Debentures are not paid in full by the maturity date, then the Company shall be obligated
to make a monthly cash payment to the holder as liquidated damages in the amount equal to 2% of the principal and interest outstanding.
The Company at its sole option may pay such liquidated damages in shares of common stock of the Company equal to the amount payable
divided by the weighted average market price for the five days prior to the payment. Such liquidated damages will be paid on a
monthly basis until this debenture is paid in full. The Secured Convertible Debenture is secured by all assets of the Company.
Each of the accredited investors have individually agreed to restrict their ability
to convert the Secured Convertible Debentures or exercise their Common Stock Purchase Warrants and receive shares of common stock
such that the number of shares of common stock held by them and their affiliates after such conversion or
exercise does not exceed 4.99% of the then issued and outstanding shares of common stock.

 

On May 13, 2015, the Company entered into a
Securities Purchase Agreement with two executive officers and directors of the Company, pursuant to which the affiliates invested
$100,000 and $50,000, respectively, into the Company in consideration of a Secured Convertible Debenture and a common stock purchase
warrant to acquire 2,727,273 and 1,363,636, respectively, shares of common stock exercisable for a period of five years at an exercise
price of $0.055 subject to antidilution protection. The Secured Convertible Debentures bear interest of 10%, are payable on the
earlier of the Company closing a financing in excess of $500,000 or September 15, 2015 and is convertible into shares of common
stock at $0.055 per share subject to antidilution protection. In the event the Secured Convertible Debentures are not paid in full
by the maturity date, then the Company shall be obligated to issues shares of common stock to the holder as liquidated damages
in the amount equal to the principal and interest outstanding multiplied by .25 per month, which such product will be divided by
the conversion price then in place. Such liquidated damages will be paid on a monthly basis until this debenture is paid in full.
The Secured Convertible Debenture is secured by all assets of the Company.

 

    

     

    

 

Schedule 2.23 – Transactions with
Affiliates

 

See the response to Schedule 2.11 above. In
February 2016, the Company entered into and closed a Share Exchange Agreement with Fin Holdings, Inc. , a Florida corporation ("FIN"),
and all of the FIN shareholders (the "FIN Shareholders"), pursuant to which the Company agreed to acquire 100% of the
issued and outstanding shares of FIN (the "FIN Shares") and FIN's two wholly-owned subsidiaries, ID Solutions, Inc. and
Cards Plus Pty Ltd. (collectively, the "Subsidiaries"), from the FIN Shareholders. In consideration for the FIN Shares,
the Company issued and sold to the FIN Shareholders an aggregate of 22,500,000 shares of common stock. Mr. Douglas Solomon, a director
and executive officer of the Company, was a shareholder of FIN and was party to the agreement.

 

Schedule 2.29 - Title to Assets

 

See the response to Schedule 2.11 above.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00261-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00261-of-00352.parquet"}]]